Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 31OTHER 20NIH 2NETWORK 2OTHER_GOV 1INDIV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Proflavine 9Microbial Collagenase 2plerixafor 1pembrolizumab 1pegfilgrastim 1olaparib 1nilotinib 1macimorelin 1keyhole-limpet hemocyanin 1ethyl pyruvate 1compound W 1blinatumomab 1Uracil 1Tegafur 1Surgical Procedures, Operative 1Sodium Chloride 1Sirolimus 1Salicylates 1Peptides 1PM 01183 1Monatide (IMS 3015) 1Mifepristone 1Gemcitabine 1Fluorescein 1Everolimus 1Doxorubicin 1Darbepoetin alfa 1Curettage 1Corlux 1Circumcision, Male 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDIV × Interventional × PM 01183 × Clear all
NCT02684318 2017-06-22

Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors

Poveda, Andrés, M.D.

Phase 1/2 Unknown
100 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡